According to the latest market report published by Credence Research, Inc. “Microbiome Sequencing Services Market – Growth, Future Prospects, and Competitive Analysis, 2017 – 2025,” the global microbiome sequencing services market was valued at US$ 498 Mn in 2016, and is expected to reach US$ 2,519.3 Mn by 2025, expanding at a CAGR of 19.6% from 2017 to 2025.

Microbiome sequencing is used to study microflora of human biota with the goal of understanding of human microbes and role played by them in health and disease. Earlier traditional microbiological techniques were used for sample from skin, blood or stool sample, to study the phenotype and genotype of the individual. With advent of technology, tool such as next generation sequencing is used to generate data of human microbiome. This kind of throughput would help in metagenomics studies. Microbiome are considered as major indication of any alteration that take place in body. Monitoring the human microbial biota, genes or output such as protein or metabolites help in measuring the disease status and predicting individual response to the treatment. Novel high-throughput sequencing and new software tools are revolutionizing microbiome study and help in providing service at high quality, speed and effective cost. Human microbiome sequencing services would be of help in commercialization of personalized medicine and diet.

The global microbiome sequencing services market is segmented by technology type into shotgun sequencing, targeted gene sequencing, RNA sequencing, whole genome sequencing and others. Shotgun sequencing dominates the microbiome sequencing services market. The global microbiome sequencing services market is segmented by application type into therapeutics, genetic screening, drug and biomarker discovery, personalised medicine and others. Therapeutics segment dominates the microbiome sequencing services market with rising prevalence of cancer and infectious diseases. Based on research type, this market is classified as outsourced and in-house. Outsourced research segment occupies the large share and highest CAGR microbiome sequencing services market in the given forecast period. The global microbiome sequencing services market is segmented by end users into pharmaceutical and biotechnology companies, academia/research institutes and others. Pharmaceutical and biotechnology companies segment dominate the microbiome sequencing services market due to rise in funding by government and venture capitalist in research and development.

As of the current market scenario, North America dominates the global microbiome sequencing services market followed by the Europe. Evolving sequencing technology, increase in government funding in genomic studies and analyses, growing interest in microbiome sequencing for exploring personalized medicine and prevention and treatment of disease are some of the major factors driving the growth of microbiome sequencing services market in North America and Europe. Asia Pacific is the fastest growing regional market for microbiome sequencing services with highest CAGR in the forecast period.